{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:23:16Z","timestamp":1793013796610,"version":"4.5.0"},"reference-count":29,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012285","name":"British Columbia Children\u2019s Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012285","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BCCH Foundation"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2658377","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:15:36Z","timestamp":1777403736000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Post-licensure safety of nirsevimab from the Canadian National Vaccine Safety (CANVAS) network"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-3831","authenticated-orcid":false,"given":"Marina","family":"Vi\u00f1eta Paramo","sequence":"first","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"British Columbia Children\u2019s Hospital Research Institute","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilou","family":"Kiely","sequence":"additional","affiliation":[{"name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval","place":["Qu\u00e9bec City, Canada"]},{"name":"Universit\u00e9 Laval","place":["Qu\u00e9bec City, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Valiquette","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Sherbrooke","place":["Sherbrooke, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Muller","sequence":"additional","affiliation":[{"name":"Unity Health Toronto","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[{"name":"Sinai Health System","place":["Toronto, Canada"]},{"name":"University of Toronto","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Isenor","sequence":"additional","affiliation":[{"name":"Dalhousie University and Canadian Center for Vaccinology","place":["Halifax, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"BC Children\u2019s Hospital Research Institute","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Kellner","sequence":"additional","affiliation":[{"name":"University of Calgary","place":["Calgary, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto G.","family":"Vanderkooi","sequence":"additional","affiliation":[{"name":"University of Calgary","place":["Calgary, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Marty","sequence":"additional","affiliation":[{"name":"BC Children\u2019s Hospital Research Institute","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2205-0362","authenticated-orcid":false,"given":"Pascal M.","family":"Lavoie","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"British Columbia Children\u2019s Hospital Research Institute","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-4174","authenticated-orcid":false,"given":"Julie A.","family":"Bettinger","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]},{"name":"BC Children\u2019s Hospital Research Institute","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)00478-0"},{"key":"e_1_3_5_3_1","unstructured":"National Advisory Committee on Immunization. Statement on the prevention of respiratory syncytial virus (RSV) disease in infants. Public Health Agency of Canada; 2024. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-summary-statement-prevention-respiratory-syncytial-virus-disease-infants.html."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2025.30.5.2400596"},{"key":"e_1_3_5_5_1","unstructured":"Centers for Disease Control and Prevention. Healthcare providers: RSV prevention information. National Center for Immunization and Respiratory Diseases. 2023 [accessed 2024 May 31]. https:\/\/www.cdc.gov\/vaccines\/vpd\/rsv\/hcp\/child.html#recommendations."},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13060503"},{"key":"e_1_3_5_7_1","unstructured":"Direcci\u00f3n Xeral de Sa\u00fade P\u00fablica. Monitoring of the nirsevimab immunisation campaign against RSV in Galicia. 2023-2024 season. Report week 9 (26\/02\/2024 to 03\/03\/2024). Servizo Galego de Sa\u00fade (Sergas); 2024 [accessed 2024 May 31]. https:\/\/www.sergas.es\/Saude-publica\/Documents\/7512\/Report_RSV_week9.pdf."},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-223376"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102986"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2471700"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1385426"},{"key":"e_1_3_5_12_1","unstructured":"Ministry of Health Government of Ontario. Respiratory syncytial virus (RSV) prevention programs. Ontario.ca. 2023 [accessed 2025 Jun 23]. http:\/\/www.ontario.ca\/page\/respiratory-syncytial-virus-rsv-prevention-programs."},{"key":"e_1_3_5_13_1","unstructured":"Gouvernement du Quebec. Immunization against respiratory syncytial virus (RSV) infections. Gouvernement du Qu\u00e9bec. [accessed 2025 Jun 9]. https:\/\/www.quebec.ca\/en\/health\/advice-and-prevention\/vaccination\/immunization-against-respiratory-syncytial-rsv-infections."},{"key":"e_1_3_5_14_1","unstructured":"IWK Health Centre. BeyfortusTM (nirsevimab). IWK Health. [accessed 2025 Jun 23]. https:\/\/iwkhealth.ca\/nirsevimab."},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.240780"},{"key":"e_1_3_5_16_1","volume-title":"Global manual on surveillance of adverse events following immunization","author":"World Health Organisation","year":"2016","unstructured":"World Health Organisation. Global manual on surveillance of adverse events following immunization. Geneva (Switzerland): World Health Organization; 2016."},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12050549"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000004715"},{"key":"e_1_3_5_19_1","unstructured":"AusVaxSafety (NCIRS). 4 months schedule point. AusVaxSafety. [accessed 2025 Aug 5]. https:\/\/ausvaxsafety.org.au\/national-immunisation-program-schedule-vaccines\/4-months-schedule-point."},{"key":"e_1_3_5_20_1","unstructured":"AusVaxSafety (NCIRS). 2 months schedule point. AusVaxSafety. [accessed 2025 Jul 7]. https:\/\/ausvaxsafety.org.au\/national-immunisation-program-schedule-vaccines\/2-months-schedule-point."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13060623"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309189"},{"key":"e_1_3_5_23_1","unstructured":"Sanofi. Beyfortus (nirsevimab). 2023 Jul. [accessed 2025 Apr 16]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761328s000lbl.pdf."},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284107"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1195751"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003499"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2556588"},{"key":"e_1_3_5_28_1","unstructured":"Government of Canada SC. The daily \u2014 the Canadian census: a rich portrait of the country\u2019s religious and ethnocultural diversity. 2022 Oct 26. [accessed 2025 Jul 31]. https:\/\/www150.statcan.gc.ca\/n1\/daily-quotidien\/221026\/dq221026b-eng.htm."},{"key":"e_1_3_5_29_1","volume-title":"The childhood immunization schedule and safety: stakeholder concerns, scientific evidence, and future studies","author":"Kulldorff M","year":"2013","unstructured":"Kulldorff M. Study designs for the safety evaluation of different childhood immunization schedules. In: Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, editor. The childhood immunization schedule and safety: stakeholder concerns, scientific evidence, and future studies. Washington (DC): National Academies Press (US); 2013. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK206950\/."},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1990-2633"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2658377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:15:42Z","timestamp":1777403742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2658377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2658377"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2658377","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2658377"}}